 Xiaofan Jia
Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| China | 42 | 2025 | 220 | 2.440 |
Why?
| | Nutrition Surveys | 24 | 2025 | 273 | 2.420 |
Why?
| | Diet | 17 | 2024 | 1282 | 1.930 |
Why?
| | Diabetes Mellitus, Type 1 | 9 | 2023 | 3776 | 1.490 |
Why?
| | Cognitive Dysfunction | 3 | 2024 | 403 | 1.220 |
Why?
| | Celiac Disease | 3 | 2023 | 295 | 0.890 |
Why?
| | Zinc Transporter 8 | 2 | 2021 | 63 | 0.890 |
Why?
| | Autoantibodies | 7 | 2023 | 1470 | 0.890 |
Why?
| | Choline | 1 | 2024 | 133 | 0.820 |
Why?
| | Dietary Proteins | 1 | 2024 | 136 | 0.810 |
Why?
| | Energy Intake | 4 | 2024 | 513 | 0.800 |
Why?
| | Dyslipidemias | 4 | 2025 | 175 | 0.790 |
Why?
| | Cohort Studies | 20 | 2025 | 5799 | 0.750 |
Why?
| | Obesity, Abdominal | 4 | 2024 | 44 | 0.720 |
Why?
| | High-Throughput Screening Assays | 2 | 2020 | 157 | 0.720 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 255 | 0.690 |
Why?
| | Autoimmune Diseases | 2 | 2020 | 464 | 0.600 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2025 | 2526 | 0.580 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2018 | 10 | 0.560 |
Why?
| | Antibodies, Viral | 2 | 2023 | 653 | 0.550 |
Why?
| | Middle Aged | 38 | 2025 | 34438 | 0.540 |
Why?
| | Nutritional Status | 5 | 2024 | 362 | 0.510 |
Why?
| | Feeding Behavior | 7 | 2024 | 681 | 0.510 |
Why?
| | Ascorbic Acid | 1 | 2018 | 179 | 0.500 |
Why?
| | Aged | 26 | 2025 | 24576 | 0.500 |
Why?
| | Adult | 40 | 2025 | 39181 | 0.480 |
Why?
| | Fruit | 5 | 2021 | 147 | 0.480 |
Why?
| | Gastrointestinal Microbiome | 4 | 2025 | 725 | 0.470 |
Why?
| | Young Adult | 25 | 2024 | 13673 | 0.450 |
Why?
| | Prevalence | 11 | 2024 | 2772 | 0.440 |
Why?
| | Hyperuricemia | 2 | 2024 | 45 | 0.440 |
Why?
| | Multimorbidity | 2 | 2025 | 53 | 0.440 |
Why?
| | Mass Screening | 3 | 2021 | 1310 | 0.440 |
Why?
| | Biomarkers | 3 | 2024 | 4175 | 0.430 |
Why?
| | Hypertension | 4 | 2024 | 1252 | 0.430 |
Why?
| | Adolescent | 30 | 2024 | 22007 | 0.420 |
Why?
| | Female | 39 | 2025 | 75522 | 0.380 |
Why?
| | Vegetables | 5 | 2024 | 161 | 0.380 |
Why?
| | Humans | 54 | 2025 | 141197 | 0.380 |
Why?
| | Male | 37 | 2025 | 69789 | 0.370 |
Why?
| | Cholesterol, Dietary | 3 | 2016 | 15 | 0.360 |
Why?
| | Luminescent Measurements | 2 | 2021 | 74 | 0.340 |
Why?
| | Obesity | 5 | 2024 | 3004 | 0.340 |
Why?
| | Risk Factors | 15 | 2025 | 10438 | 0.330 |
Why?
| | Snacks | 2 | 2022 | 24 | 0.320 |
Why?
| | Waist Circumference | 3 | 2024 | 134 | 0.300 |
Why?
| | Prospective Studies | 7 | 2025 | 7739 | 0.280 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5636 | 0.270 |
Why?
| | Incidence | 3 | 2024 | 2794 | 0.270 |
Why?
| | Urbanization | 3 | 2022 | 27 | 0.250 |
Why?
| | Body Mass Index | 7 | 2024 | 2382 | 0.240 |
Why?
| | Eating | 3 | 2024 | 392 | 0.230 |
Why?
| | Glutamate Decarboxylase | 2 | 2022 | 166 | 0.220 |
Why?
| | Mental Status and Dementia Tests | 2 | 2021 | 27 | 0.220 |
Why?
| | Mycobiome | 1 | 2024 | 7 | 0.220 |
Why?
| | Iron, Dietary | 1 | 2024 | 22 | 0.220 |
Why?
| | Cardiovascular Diseases | 4 | 2025 | 2087 | 0.220 |
Why?
| | Selenium | 1 | 2024 | 49 | 0.220 |
Why?
| | Seroepidemiologic Studies | 2 | 2023 | 166 | 0.210 |
Why?
| | Copper | 1 | 2024 | 114 | 0.210 |
Why?
| | Dietary Carbohydrates | 1 | 2024 | 153 | 0.210 |
Why?
| | Metabolic Diseases | 1 | 2024 | 114 | 0.200 |
Why?
| | Micronutrients | 2 | 2021 | 92 | 0.200 |
Why?
| | Restaurants | 1 | 2022 | 23 | 0.190 |
Why?
| | Dietary Fats | 1 | 2024 | 300 | 0.190 |
Why?
| | Sodium, Dietary | 1 | 2022 | 39 | 0.190 |
Why?
| | Pediatric Obesity | 2 | 2021 | 600 | 0.190 |
Why?
| | Nutritional Requirements | 2 | 2024 | 81 | 0.190 |
Why?
| | Sex Factors | 3 | 2024 | 2059 | 0.190 |
Why?
| | Overweight | 2 | 2024 | 587 | 0.190 |
Why?
| | Osteopontin | 1 | 2022 | 31 | 0.190 |
Why?
| | Stroke | 2 | 2024 | 1154 | 0.180 |
Why?
| | C-Reactive Protein | 1 | 2024 | 418 | 0.180 |
Why?
| | Mental Status Schedule | 1 | 2021 | 34 | 0.180 |
Why?
| | Electrochemistry | 1 | 2021 | 76 | 0.180 |
Why?
| | Child Nutrition Disorders | 1 | 2021 | 20 | 0.180 |
Why?
| | Zinc | 1 | 2024 | 299 | 0.180 |
Why?
| | Child | 10 | 2023 | 22310 | 0.170 |
Why?
| | Electrochemical Techniques | 1 | 2020 | 53 | 0.170 |
Why?
| | Lymphopenia | 1 | 2020 | 67 | 0.160 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1973 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 122 | 0.160 |
Why?
| | Logistic Models | 3 | 2021 | 2086 | 0.150 |
Why?
| | Nutrition Policy | 1 | 2019 | 61 | 0.150 |
Why?
| | Malnutrition | 1 | 2020 | 85 | 0.150 |
Why?
| | Longitudinal Studies | 6 | 2024 | 2902 | 0.150 |
Why?
| | Rural Population | 4 | 2024 | 604 | 0.150 |
Why?
| | Diabetes Mellitus | 2 | 2024 | 1074 | 0.150 |
Why?
| | Age Factors | 2 | 2024 | 3292 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2021 | 338 | 0.150 |
Why?
| | Calcium, Dietary | 1 | 2018 | 57 | 0.140 |
Why?
| | Food, Preserved | 1 | 2018 | 2 | 0.140 |
Why?
| | Autoantigens | 1 | 2021 | 422 | 0.140 |
Why?
| | Diet Surveys | 3 | 2024 | 91 | 0.140 |
Why?
| | Vitamin A | 1 | 2018 | 57 | 0.140 |
Why?
| | Nuts | 1 | 2018 | 13 | 0.140 |
Why?
| | Beverages | 1 | 2018 | 67 | 0.140 |
Why?
| | Health Status | 1 | 2023 | 823 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 93 | 0.140 |
Why?
| | Anthropometry | 1 | 2018 | 208 | 0.130 |
Why?
| | Urban Population | 3 | 2024 | 485 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 276 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 372 | 0.130 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1306 | 0.130 |
Why?
| | Neuropsychological Tests | 1 | 2021 | 1085 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2022 | 3588 | 0.130 |
Why?
| | Cognition | 2 | 2022 | 1222 | 0.120 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7856 | 0.120 |
Why?
| | Aerosols | 1 | 2016 | 181 | 0.120 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1403 | 0.120 |
Why?
| | Proteomics | 1 | 2022 | 1135 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2021 | 5200 | 0.120 |
Why?
| | Patient Compliance | 1 | 2019 | 610 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 371 | 0.110 |
Why?
| | Infant | 4 | 2023 | 9818 | 0.110 |
Why?
| | Colorado | 2 | 2023 | 4610 | 0.110 |
Why?
| | Proportional Hazards Models | 3 | 2025 | 1261 | 0.110 |
Why?
| | Child, Preschool | 4 | 2023 | 11457 | 0.110 |
Why?
| | Environmental Monitoring | 1 | 2016 | 371 | 0.110 |
Why?
| | Cholesterol, LDL | 1 | 2015 | 361 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4073 | 0.100 |
Why?
| | Air Pollution | 1 | 2016 | 322 | 0.100 |
Why?
| | Air Pollutants | 1 | 2016 | 430 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1128 | 0.090 |
Why?
| | Depression | 1 | 2021 | 1483 | 0.090 |
Why?
| | Liver Failure | 1 | 2010 | 80 | 0.080 |
Why?
| | Hepatitis B | 1 | 2010 | 69 | 0.080 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2022 | 557 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5929 | 0.080 |
Why?
| | Chronic Disease | 2 | 2024 | 1816 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 593 | 0.070 |
Why?
| | Mass Spectrometry | 1 | 2010 | 739 | 0.070 |
Why?
| | Metabolomics | 1 | 2010 | 705 | 0.060 |
Why?
| | Blood Pressure | 2 | 2023 | 1748 | 0.060 |
Why?
| | Fast Foods | 1 | 2022 | 17 | 0.050 |
Why?
| | Transglutaminases | 1 | 2023 | 156 | 0.050 |
Why?
| | Sodium | 1 | 2022 | 196 | 0.050 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2021 | 17 | 0.040 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.040 |
Why?
| | Fasting | 1 | 2022 | 284 | 0.040 |
Why?
| | Virus Shedding | 1 | 2020 | 48 | 0.040 |
Why?
| | Asymptomatic Infections | 1 | 2020 | 36 | 0.040 |
Why?
| | Zoonoses | 1 | 2020 | 38 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2020 | 167 | 0.040 |
Why?
| | Multilevel Analysis | 1 | 2020 | 35 | 0.040 |
Why?
| | Cities | 1 | 2020 | 134 | 0.040 |
Why?
| | Farmers | 1 | 2020 | 70 | 0.040 |
Why?
| | Virulence | 1 | 2020 | 268 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2020 | 273 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 352 | 0.040 |
Why?
| | Meat Products | 1 | 2018 | 27 | 0.040 |
Why?
| | Seafood | 1 | 2018 | 27 | 0.040 |
Why?
| | Body Composition | 1 | 2022 | 701 | 0.040 |
Why?
| | Plants, Edible | 1 | 2018 | 7 | 0.040 |
Why?
| | Dairy Products | 1 | 2018 | 30 | 0.040 |
Why?
| | Recommended Dietary Allowances | 1 | 2018 | 19 | 0.040 |
Why?
| | Genome, Viral | 1 | 2020 | 223 | 0.040 |
Why?
| | Carotenoids | 1 | 2018 | 42 | 0.040 |
Why?
| | Eggs | 1 | 2018 | 29 | 0.040 |
Why?
| | Exercise | 2 | 2020 | 2103 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2022 | 647 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2019 | 521 | 0.030 |
Why?
| | Cost of Illness | 1 | 2020 | 312 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3348 | 0.030 |
Why?
| | Meat | 1 | 2018 | 93 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 463 | 0.030 |
Why?
| | Autoimmunity | 1 | 2023 | 908 | 0.030 |
Why?
| | Weight Loss | 1 | 2023 | 789 | 0.030 |
Why?
| | Population Surveillance | 1 | 2020 | 481 | 0.030 |
Why?
| | Beijing | 1 | 2016 | 2 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 519 | 0.030 |
Why?
| | Environmental Pollution | 1 | 2016 | 21 | 0.030 |
Why?
| | Sulfates | 1 | 2016 | 49 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 633 | 0.030 |
Why?
| | Animals | 4 | 2022 | 37663 | 0.030 |
Why?
| | Nitrates | 1 | 2016 | 97 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 505 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2020 | 510 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2020 | 792 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 1018 | 0.030 |
Why?
| | Carbon | 1 | 2016 | 204 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2021 | 804 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 1000 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 668 | 0.030 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 101 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 546 | 0.030 |
Why?
| | Particulate Matter | 1 | 2016 | 330 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 837 | 0.030 |
Why?
| | Water | 1 | 2016 | 464 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2889 | 0.020 |
Why?
| | Regression Analysis | 1 | 2015 | 1020 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3166 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2793 | 0.020 |
Why?
| | Blood Glucose | 1 | 2022 | 2269 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2020 | 2003 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1654 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3490 | 0.020 |
Why?
| | Glycerylphosphorylcholine | 1 | 2010 | 6 | 0.020 |
Why?
| | Brain | 1 | 2022 | 2858 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2255 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 194 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2010 | 136 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1893 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6956 | 0.020 |
Why?
| | United States | 1 | 2023 | 15220 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2020 | 11120 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2520 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5629 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2020 | 16273 | 0.010 |
Why?
|
|
Jia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|